Metka Volavšek

749 citations
38 papers · 460 indexed · h-index 13

Metka Volavšek

36 papers receiving 452 citations

Peers

Metka Volavšek
Comparison fields: 5 of 72
  • Otorhinolaryngology 65
  • Periodontics 37
  • Cancer Research 63
  • Oral Surgery 27
  • Pulmonary and Respiratory Medicine 117
Replace A. W. CASLIN with:
A. W. CASLIN United Kingdom
Hari Prasad Dhakal Norway
T. Shibahara Japan
Torbjörn Stene Norway
Simone de Queiroz Chaves Lourenço Brazil
Yan Monnier Switzerland
Johannes Doescher Germany
G. Raspall Spain
Ian Cole Australia
Şirin Başpınar Türkiye
Metka Volavšek relative to A. W. CASLIN United Kingdom A. W. CASLIN's profile →
Citations per field
00.5×10×15×20×24×
A. W. CASLIN · 1×
Citations per year

Countries citing papers authored by Metka Volavšek

Since Specialization
Citations

This map shows the geographic impact of Metka Volavšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Metka Volavšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Metka Volavšek more than expected).

Fields of papers citing papers by Metka Volavšek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Metka Volavšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Metka Volavšek. The network helps show where Metka Volavšek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Metka Volavšek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Metka Volavšek Line = papers co-authored together Metka Volavšek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 20233
4 202219
5 20214
6 20202
7 202026
8 20193
9 20179
10 20160
11 201320
12 200918
13 200937
14 200841
15 20071
16 200622
17 200314
18
CELL CYCLE REGULATING GENES AND THEIR PROTEIN EXPRESSION IN SQUAMOUS CELL CARCINOMA OF THE LARYNX AND HYPOPHARYNX
20021
19 19966
20 19924

About Metka Volavšek

Metka Volavšek is a scholar working on Otorhinolaryngology, Rheumatology and Oncology, having authored 38 papers that have together received 460 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (5 papers), Tumors and Oncological Cases (4 papers), Head and Neck Cancer Studies (4 papers), Gastrointestinal disorders and treatments (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Otorhinolaryngology (65 citations), Periodontics (37 citations) and Cancer Research (63 citations). Metka Volavšek has collaborated with scholars based in Slovenia, Spain and United States. Frequent co-authors include Damjan Glavač, Nina Gale, Nina Zidar, Antonio Cardesa, Metka Ravnik‐Glavač, Janez Lamovec, Mara Popović, Ann Sandison, Timothy R. Helliwell and Matej Bračko. Their work appears in journals such as SHILAP Revista de lepidopterología, Kidney International and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026